Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
October 03, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, OCTOBER 03, 2023
Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine

Coronavirus chronicle

Reuters
12 January, 2021, 02:05 pm
Last modified: 12 January, 2021, 02:15 pm

Related News

  • China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study
  • Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study
  • The economic vaccine jabs
  • Pfizer submits data for Coivd-19 vaccine in younger children
  • India to provide vaccines to Bangladesh if production goes up: Dr Hasan Mahmud

Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine

Pharmaniaga said that the company will carry out a fill-and-finish process of the vaccine in Malaysia and will subsequently enter into local manufacturing under license from Sinovac for its technology and know-how

Reuters
12 January, 2021, 02:05 pm
Last modified: 12 January, 2021, 02:15 pm
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

Malaysia Pharmaniaga Bhd has signed an agreement with China's Sinovac to purchase 14 million doses of ready-to-fill Covid-19 vaccines and later to manufacture the vaccine domestically, it said on Tuesday.

Pharmaniaga said in a bourse filing that the company will carry out a fill-and-finish process of the vaccine in Malaysia, and will subsequently enter into local manufacturing, under license from Sinovac for its technology and know-how.

Group Managing Director Zulkarnain Md Eusope said the company has a monthly fill-and-finish capacity of two million doses and that Sinovac's vaccine will be the first to be manufactured in Malaysia.

"Upon approval from the (local pharmaceutical regulator), we are confident to manufacture and have the vaccine ready to be distributed to the hospitals by the end of March," he said at the signing event.

The government-backed firm said the agreement will also help it in long-term partnerships, including technology transfers to grow the sector in Malaysia.

Science, Technology and Innovation Minister Khairy Jamaluddin said Malaysia would be able to procure the 14 million doses of vaccine through Pharmaniaga at a lower price than if procured directly from Sinovac.

"We will finalise the government procurement part of it hopefully by next week," he added.

Malaysia has been in talks to secure a total of 23.9 million doses of Covid-19 vaccines from Sinovac and another Chinese manufacturer CanSino Biologics, and from Russia's Gamaleya Institute, the maker of the Sputnik V vaccine.

The Southeast Asian nation has also procured coronavirus vaccines from U.S. and German drugmakers Pfizer and BioNTech, as well as British-Swedish biopharmaceutical firm AstraZeneca PLC.

Sinovac Biotech / Sinovac Covid-19 Vaccine / Sinovac vaccine / Chinese Sinovac company / Malaysia Pharmaniaga Bhd / Covid-19 vaccines / Vaccine acceptance / Vaccine availability

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Cenbank finally moves to make money costlier to fight inflation
    Cenbank finally moves to make money costlier to fight inflation
  • U.S. Dollar and Euro banknotes are seen in this illustration taken July 17, 2022. REUTERS/Dado Ruvic/Illustration
    Hopes for $30b reserve by June amid concerns to meet IMF threshold
  • 5.3 magnitude earthquake jolts Bangladesh
    5.3 magnitude earthquake jolts Bangladesh

MOST VIEWED

  • Representational image. Photo: Collected
    Why Bangladesh’s reserves tumble, Sri Lanka’s improve
  • Big drops in remittance, exports make reserves struggle harsher
    Big drops in remittance, exports make reserves struggle harsher
  • No source tax can be deducted from IT freelancing sector: Cenbank
    No source tax can be deducted from IT freelancing sector: Cenbank
  • Illustration: TBS
    Why do Bangladeshi universities fare so poorly in global rankings?
  • File Photo: PMO
    PM to inaugurate 4 mega projects this month
  • Shahjahan Bhuiyan’s parents and two out of his three siblings passed away when he was behind bars. He missed all the funerals.  
Photo: Nayem Ali
    Hangman Shahjahan Bhuiyan: Life after 60 executions and 44 years in prison

Related News

  • China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study
  • Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: Study
  • The economic vaccine jabs
  • Pfizer submits data for Coivd-19 vaccine in younger children
  • India to provide vaccines to Bangladesh if production goes up: Dr Hasan Mahmud

Features

The Dassler brothers before the fallout. Rudolf (left) and Adi (right). At the center is track and field athlete Josef Waitzer who helped the brothers make Dassler shoes in the beginning. Photo credit: Adi & Käthe Dassler Memorial Foundation

Adidas and Puma: How a sibling rivalry gave rise to two giants of the sports world

11h | Features
Photo: Collected

Simply Khulna: When food packs a punch

16h | Food
Photo: Collected

Where did hamburgers come from?

17h | Food
Shahjahan Bhuiyan’s parents and two out of his three siblings passed away when he was behind bars. He missed all the funerals.  
Photo: Nayem Ali

Hangman Shahjahan Bhuiyan: Life after 60 executions and 44 years in prison

22h | Panorama

More Videos from TBS

Ukraine is preparing for uninterrupted power supply in winter

Ukraine is preparing for uninterrupted power supply in winter

11h | TBS World
Everything about the ICC Cricket World Cup 2023 stadiums: Part 2

Everything about the ICC Cricket World Cup 2023 stadiums: Part 2

9h | TBS SPORTS
Without ‘big brothers’, many actresses would go hungry - Zayed Khan

Without ‘big brothers’, many actresses would go hungry - Zayed Khan

10h | TBS Entertainment
Remittances fall to lowest in 41 months, export growth also declining

Remittances fall to lowest in 41 months, export growth also declining

16h | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]